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Abstract
Background: Bile acids, end products of the pathway for cholesterol elimination, are required for dietary lipid and fat-
soluble vitamin absorption and maintain the balance between cholesterol synthesis in the liver and cholesterol excretion.
They are composed of a steroid structure and are primarily made in the liver by the oxidation of cholesterol. Cholesterol is
also highly abundant in the human ovarian follicle, where it is used in the formation of the sex steroids.
Methodology/Principal Findings: Here we describe for the first time evidence that all aspects of the bile acid synthesis
pathway are present in the human ovarian follicle, including the enzymes in both the classical and alternative pathways, the
nuclear receptors known to regulate the pathway, and the end product bile acids. Furthermore, we provide functional
evidence that bile acids are produced by the human follicular granulosa cells in response to cholesterol presence in the
culture media.
Conclusions/Significance: These findings establish a novel pathway present in the human ovarian follicle that has the
capacity to compete directly with sex steroid synthesis.
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Introduction
Bile acids are powerful detergents with essential functions in
lipid and cholesterol processing. They play key roles in the
gastrointestinal and hepatobiliary systems, are required for dietary
lipid and fat-soluble vitamin absorption, and maintain the balance
between cholesterol synthesis in the liver and cholesterol excretion
[1–3]. Bile acids are composed of a steroid structure and are made
primarily in the liver by the oxidation of cholesterol. The synthesis
of bile acids and their localization are very tightly regulated due to
their membrane and epithelial toxicity [3,4].
Bile acid synthesis can occur through two pathways: the classic
(neutral) pathway or the alternative (acidic) pathway [5]. The classic
pathway occurs in the liver, and accounts for approximately 90% of
bile acid synthesis. The alternative pathway produces the remaining
10% of bile acids and is primarily extrahepatic. The classical
pathway begins with the rate-limiting 7-a hydroxylation of
cholesterol by cholesterol 7-a hydroxylase (CYP7A1) and the 12-a
hydroxylation of the intermediates by sterol 12-a hydroxylase
(CYP8B1),followedbyside chainoxidationbysterol27hydroxylase
(CYP27A1) [2,6–8]. The alternative pathway begins with the
hydroxylation of the cholesterol side chain by sterol 27 hydroxylase
(CYP27A1) in extrahepatic sites including vascular endothelium
and macrophages, followed by 7-a hydroxylation of the oxysterol
intermediates by oxysterol 7-a hydroxylase (CYP7B1) [6,9].
There are well-known feedback loops controlling gene tran-
scription of the major enzymes in bile acid synthesis, especially
CYP7A1 and CYP8B1 [6,7,10–12]. The nuclear receptors that
have been demonstrated to regulate the bile acid synthesis cascade
include the Farnesoid X Receptor (FXR), Retinoid X Receptor a
(RXRa), Liver X Receptor a (LXRa), and Liver Receptor
Homologue 1 (LRH-1) [6,13–15]. Only LRH-1 has been
previously studied in steroidogenic tissue, including ovaries, from
mice and rats [16–18].
In addition to its presence in the gastrointestinal and
hepatobiliary systems, cholesterol is known to be highly abundant
in the human ovarian follicle, where it is used in the formation of
the sex steroids [19–21]. The human ovarian follicle is the fluid-
filled sac that contains the oocyte (egg), and is lined with granulosa
cells which house the enzymatic machinery to participate in sex
steroid synthesis. Given the high content of both cholesterol and
the sex steroids in the human ovarian follicles, we searched for the
presence of bile acids in the ovarian follicular fluid [22].
Here we describe for the first time evidence that all aspects of
the bile acid synthesis pathway are present in the human ovarian
follicle, including the enzymes in both the classical and alternative
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and the end product bile acids. Furthermore, we provide
functional evidence that bile acids are produced by the human
follicular granulosa cells in response to cholesterol presence in the
culture media. These findings establish a novel pathway present in
the human ovarian follicle that has the capacity to compete
directly with sex steroid synthesis.
Results
Bile Acids are Present in Human Ovarian Follicular Fluid
Follicular fluid (FF) from mature follicles from 93 patients was
obtained during in vitro fertilization (IVF). The individual FF
samples were analyzed in duplicate for content of total bile acids
by enzymatic assay. The mean bile acid concentration in FF was
measured to be 17.301 mM (STD 6 5.41) (Figure 1, a). The origin
of bile acids in FF is not known. They could enter the follicle
through the blood, or they could be synthesized in the follicular
compartment. In the case of diffusion from blood, their content in
FF and serum is expected to be nearly identical. Alternately, active
bile acid synthesis within the follicle could result in a higher
follicular content compared to serum. In order to investigate the
bile acids origin we compared content in blood and FF in 19 of the
patients. The mean concentration of bile acids in serum obtained
within 30 minutes of FF collection was found to be 7.672 mM
(STD 6 2.548) (Figure 1, b). This dramatic difference of bile acid
content in FF and serum is surprising and statistically significant
(p,0.000001). The IVF procedure includes treatment with human
chorionic gonadotropin (hCG). It is likely that the observed
difference is a result of the hCG treatment. Therefore, we
compared bile acid content in blood collected 24 hours before and
36 hours after hCG administration in 13 of these patients to
evaluate the impact of hCG administration on bile acid content
(Figure 1, c). The mean pre-hCG bile acid concentration in the
serum of the 13 samples was measured to be higher (13.61 mM,
STD 6 5.47) than in the post-hCG serum (7.672 mM)
(p=0.00064). The mean pre-hCG bile acid concentration in the
serum (13.61 mM ) was lower than in the corresponding FF
(17.301 mM) but this difference was not statistically significant
(p=0.185). The highly significant difference in the bile acid
content between FF and the post-hCG serum obtained within 30
minutes of FF collection supports the proposal for active
intrafollicular ovarian synthesis.
This is the first demonstration of the presence of bile acids in this
compartment. The high cholesterol concentration in the follicle is
likely to be supporting not only active steroidogenesis but also
synthesis of bile acids. This finding raises the obvious question of
whether the enzymes responsible for bile acid synthesis are present in
the ovarian follicle. The intrafollicular synthesis of bile acids could be
facilitated by activities within the granulosa cells, the oocyte, or both.
Figure 1. Presence of bile acids in human ovarian follicular fluid. Bile acid concentration was measured in FF (Panel a), in FF compared to
post-HCG serum (Panel b), and in pre-HCG serum compared to post-HCG serum (Panel c).
doi:10.1371/journal.pone.0007333.g001
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in the Ovarian Follicle
Initially, we applied gene chip array to search for the presence of
mRNA transcripts of these enzymes in granulosa cells from 10
patients. The assay identified the presence of mRNA for the key
enzymes in the classical and the alternative pathways of bile acid
synthesis: CYP7A1, CYP27A1, CYP7B1, and CYP8B1 (Figure 2a).
Next, the presence of these genes was verified at the protein level by
immunofluorescence (IF) with specific antibodies. Granulosa cells
from four different patients were analyzed for the presence of
CYP7A1, CYP27A1, CYP7B1, and CYP8B1. Specific positive
staining was registered for enzymes from both the classical and
alternative pathways of bile acid synthesis, including CYP7A1, the
rate-limiting enzymein the classical pathway, CYP27A1, the first and
rate-limiting enzyme of the alternative pathway, and CYP7B1 from
the alternative pathway of bile acid synthesis (Figure 2b, panel A).
The enzyme CYP8B1 was not detected in granulosa cells. Although
the result was negative, it served as IF specificity control (not shown).
It is possible that the oocytes whichresidewithintheovarian follicle
also participate in the synthesis of bile acids. We analyzed discarded,
non-fertilized human oocytes by IF with specific antibodies for the
key enzymes in both bile acid synthesis pathways. We identified
specific positive staining of CYP7A1, CYP7B1, and CYP8B1
(Figure 2b, panel C). The immunostaining for CYP27A1 from the
alternative pathway was negative (not shown). Bile acid enzyme data
from IF in granulosa cells and oocytes are summarized in Table 1.
The Bile Acid Synthesis Pathway is Functional in the
Ovarian Follicle
To test for bile acids synthesis in granulosa cells we cultured
primary human cumulus granulosa cells (CGC) and exposed them
to media containing different cholesterol concentrations
(13.95mg/dL, 26.09mg/dL, 46.15mg/dL) loaded in human low
density lipoprotein (LDL) particles. After 48 hours culture medium
and cells have been analyzed for presence of bile acids at time 0
Figure 2. Presence of enzymes and receptors regulating the classical and alternative pathways of bile acid synthesis. In the cytosol of
granulosa cells, specific positive staining was registered for CYP7A1 (Panel A, image 1), CYP27A1 (Panel A, image 2), and CYP7B1 (Panel A, image 3).
Specific positive staining for Inhibin b was used to confirm granulosa cell type (Panel A, image 4). In oocytes, specific positive staining was identified
for CYP7A1 (Panel C, image 1), CYP7B1 (Panel C, image 2), and CYP8B1 (Panel C, image 3). The receptors known to regulate the bile acid synthesis
pathway were also present in granulosa cells and oocytes. In granulosa cells, specific positive staining was registered for FXR (Panel B, image 1), LRH-1
(Panel B, image 2), and RXRa (Panel B, image 3). Using western blot of granulosa cells, a specific reacting band for the receptor LXRa was observed
(Panel B, image 4). In human oocytes, specific positive staining was also demonstrated for the receptors FXR (Panel D, image 1), RXRa (Panel D, image
2), and LRH-1 (Panel D, image 3). Secondary antibody controls are presented in images 4 of Panels C and D.
doi:10.1371/journal.pone.0007333.g002
Table 1. Presence of bile acids synthesis enzymes in human
ovarian follicle.
Classical Pathway Enzyme Granulosa Cells Oocytes
CYP7A1 present present
CYP8B1 absent present
CYP27A1 present absent
Alternative Pathway Enzyme
CYP27A1 present absent
CYP7B1 present present
Protein presence was analyzed with enzyme specific antibodies and
immunofluorescence. Present - the enzyme is present at a protein level; absent
- the enzyme is not present at a protein level.
doi:10.1371/journal.pone.0007333.t001
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measured a CGC-specific dose-dependent increase in production
of bile acids in response to increasing cholesterol in CGC media
(Figure 3). The results of this experiment clearly demonstrate that
CGC respond to changes in cholesterol concentration by
synthesizing bile acids. This suggests that the enzymes which we
have identified to be present in the granulosa cells are part of a
functional pathway in these cells. The presence of all major
constituents of the classical pathway, including elements never
found outside the liver is curious and novel. The relative
contributions of the classical and alternative pathways to the
observed bile acid synthesis remains to be determined.
Receptors Known to Regulate the Bile Acid Synthesis
Pathway are Present in the Ovarian Follicle
The bile acid synthesis pathway is known to be regulated by
nuclear receptors. We examined primary human granulosa cells
and discarded, non-fertilized oocytes for presence of FXR, RXRa,
LXRa, and LRH-1 by protein-specific antibodies and IF. FXR,
which is known to have as its ligand bile acids, was found to be
present in the cytosol of granulosa cells (Figure 2, panel B) as well
as in the oocytes (Figure 2, panel D) [11–13]. To our knowledge,
this is the first report of this receptor in the human ovary.
Furthermore, by staining granulosa cells and oocytes with RXRa
and LRH-1 specific antibodies we observed specific positive
staining for both receptors in three independent experiments with
cells from three different patients (Figure 2, panels B and D). The
receptor LXRa has never been previously described in the human
ovary [6,23–25]. By applying western blot (WB) with LXRa
specific antibodies we consistently observed specifically reacting
64kDa band that correspond to LXRa in granulosa cell lysates
from four different healthy patients (Figure 2, panel B). Data for
presence of receptors from the bile acids pathways are summarized
in Table 2.
Discussion
Our results strongly argue for the presence of all of the
components of the bile acid synthesis pathway, including the key
enzymes in bile acid synthesis as well as the receptors that regulate
expression of these enzymes, and the end product bile acids. To
our knowledge, this is the first report of this pathway in the human
ovary.
Although it is widely accepted that the classical pathway of bile
acid synthesis is present only in the liver, our data clearly suggests
that the key enzymes from both the classical and alternative
synthesis pathways are present in the ovarian granulosa cells and
oocytes. To our knowledge, these findings are the first demon-
stration for presence of CYP7A1, CYP27A1, CYP7B1, and
CYP8B1 at both mRNA and protein level in granulosa cells. This
is also the first demonstration of the presence of these enzymes in
the oocytes as proteins. CYP7A1 is considered to be a liver-specific
enzyme, although it has been reported to be present in human
prostate [6]. CYP27A1 has been identified in a wide range of
extrahepatic tissues, but has not been previously reported in the
human ovary [26]. CYP8B1 has only been identified in the liver
prior to our experimental results [27]. CYP7B1 is known to have
wide tissue distribution, but has not been previously identified in
the human ovarian follicle [9]. The presence of bile acids and the
key enzymes of both pathways in ovarian follicles suggests for the
presence of a fully functional ovarian pathway locally producing
bile acids. Presently it is not clear whether bile acids have been
synthesized mainly by the granulosa cells, oocytes, or both.
Our results suggest that granulosa cells have the key enzymes to
synthesize bile acids from cholesterol, and that this is an active
Figure 3. Bile acid production in primary cultured human
cumulus granulosa cells (CGC). Cholesterol entering granulosa cells
may be used to form sex steroids or bile acids (Panel a). With increasing
cholesterol concentration in media, CGC demonstrate dose-dependent
bile acid content (Panel b).
doi:10.1371/journal.pone.0007333.g003
Table 2. Presence of receptors known to regulate the bile
acids synthesis pathways.
Receptor Granulosa Cells Oocytes
FXR present, IF present, IF
RXR alpha present, IF present, IF
LRH1 present, IF present, IF
LXR alpha present, WB absent
Protein presence was analyzed with receptor specific antibodies and either
immunofluorescence (IF) or western blot (WB). (Present) – the receptor is
present at a protein level; (absent) – the receptor is not present at a protein
level.
doi:10.1371/journal.pone.0007333.t002
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steroidogenesis and degradation in the bile acid pathway is not
known, but most likely there is a fine balance which may prove
crucial to oocyte maturation. In support of this hypothesis are
recently published experimental data with rodents where a role for
LRH-1 in steroidogenesis, gonadal development, aromatase
expression, and progesterone biosynthesis was clearly documented
[17,28]. Another recent study has linked LRH-1 with ovulation in
a rodent model, demonstrating that this receptor is required for
rodent ovarian follicular development and fertility [17].
Given that the ovarian follicle is a highly privileged environ-
ment, it is likely that bile acids play a specific role beyond simply
acting as detergents and carriers of cholesterol. Full characteriza-
tion of the follicular-specific role of bile acids remains to be
determined.
Methods
Ethics statement
Follicular fluid, granulosa cells and blood serum were obtained
under Beth Israel Deaconess Medical Center (BIDMC) IRB
approval (Protocol #2003-P-000289) after appropriate written
informed consent from women undergoing in IVF. Discarded,
non-fertilized metaphase II human oocytes were obtained under
BIDMC IRB approval with waiver of informed consent from IVF
cycles in which oocytes failed to fertilize and would have otherwise
been discarded. Waiver of informed consent for discarded, non-
fertilized oocytes was granted by BIDMC IRB because no patient-
identifying information was obtained with the pooled, anonymous
samples of discarded tissue, and no protected health information
was used.
Follicular fluid, granulosa cell, serum, and discarded, non-
fertilized oocyte collection and processing
All follicular fluid from large (mean diameter .16mm) follicles,
granulosa cells and blood plasma retrievals have been performed
at the Boston IVF Surgery Center of Waltham, MA as previously
described [29]. Discarded, non-fertilized metaphase II human
oocytes were obtained under BIDMC IRB approval with waiver of
informed consent from IVF cycles in which oocytes failed to
fertilize and would have otherwise been discarded. Oocytes were
fixed in 4% paraformaldehyde for 20 minutes at RT and stored at
4uC for immunofluorescent analyses.
Total bile acid assays
Total bile acid concentration in follicular fluid and cell culture
media was determined using the BioQuant Total Bile Acids Assay
Kit (Enzymatic Cycling, San Diego, CA) as recommended by the
supplier. All assays have been repeated in duplicate. Statistical
comparisons were made using Microsoft Office Excel 2003 SP2
version 5.1.2600 (Redmond, WA) with p value ,0.05 considered
statistically significant.
Western blot and Immunofluorescence
Standard technique has been used for western blotting and
immunofluorescence [29]. The primary antibodies that have been
used are: monoclonal mouse anti-human Farnesoid X receptor
(Lifespan Biosciences), polyclonal rabbit anti-human Retinoid X
receptor a (Santa Cruz), polyclonal rabbit anti-human Liver X
Receptor a (Abcam), monoclonal mouse anti-human Liver
Receptor Homolog 1 (R+D Systems), polyclonal goat anti-human
CYP7A1 (Santa Cruz), polyclonal goat anti-human CYP7B1
(Santa Cruz), polyclonal goat anti-human CYP8B1 (Santa Cruz),
polyclonal goat anti-human CYP27A1 (Santa Cruz), and poly-
clonal goat anti-human Inhibin b (Santa Cruz).
Granulosa cell culture and bile acids content analysis
Primary granulosa cells (passage 4 or less) have been cultured in
six wells plates to 70% confluence in DMEM, 10% fetal calf serum
(FCS), 2.5 ng/mL bFGF (Sigma Aldrich), and 25 mg/mL
Amphotericin B. Cholesterol (Sigma) was added to the cell culture
medium as a LDL complex in the following concentrations:
13.95mg/dL, 26.09mg/dL, 46.15mg/dL. After 48 hours incuba-
tion with cholesterol, the culture medium from each well has been
removed and stored for cholesterol and bile acids content assay.
Cells have been also collected to measure the protein content in
the individual wells and use it as a base for comparison. Incubation
with LDL alone without cholesterol addition has been used as
negative control. All measurements have been performed in
duplicates and in three independent experiments with different
preparations of primary cell cultures. The cholesterol content in
the culture mediums was measured by the Cholesterol Liquid
Color Assay (StanBio, Boerne TX) as recommended by the
supplier. BioQuant Total Bile Acids Assay Kit (San Diego, CA)
was used to determine the bile acids content. After removing the
culture medium the total cellular protein amount in each well was
measured by the Lawry method (Bio-Rad kit) and used as a base
for comparison.
Granulosa cell gene expression profiling
Pooled GC RNA from 10 patients was analyzed for gene
expression profile using Agilent gene chip array. Ingenuity Systems
Pathway Analysis Software (Redwood City, CA) was used to
interpret microchip array data.
Author Contributions
Conceived and designed the experiments: LPS MN ASP ET AU.
Performed the experiments: LPS MN SWY AU. Analyzed the data: LPS
MN SWY ASP AU. Wrote the paper: LPS AU.
References
1. Javitt NB (1994) Bile acid synthesis from cholesterol: regulatory and auxiliary
pathways. FASEB J 8: 1308–1311.
2. Chiang JYL (1998) Regulation of bile acid synthesis. Front Biosci 3: d176–193.
3. Raufman J-P, Cheng K, Zimniak P (2003) Activation of Muscarinic Receptor
Signaling by Bile Acids: Physiological and Medical Implications. Dig Dis Sci 48:
1431–1444.
4. Torchia EC, Stolz A, Agellon LB (2001) Differential modulation of cellular
death and survival pathways by conjugated bile acids. BMC Biochem: http://
www.biomedcentral.com/1471-2091/2/11.
5. Ferdinandusse S, Houten SM (2006) Peroxisomes and bile acid synthesis.
Biochim et Biophys Acta 1763: 1427–1440.
6. Norlin M, Wikvall K (2007) Enzymes in the Conversion of Cholesterol into Bile
Acids. Curr Mol Med 7: 199–218.
7. Nguyen LB, Guorong X, Shefer S, Tint GS, Batta A, et al. (1999) Comparative
Regulation of Hepatic Sterol 27-Hydroxylase and Cholesterol 7a-Hydroxylase
Activities in the Rat, Guinea Pig, and Rabbit: Effects of Cholesterol and Bile
Acids. Metab 48: 1542–1548.
8. Hasler JA (1999) Pharmacogenetics of human cytochromes P450. Mol Aspect
Med 20: 1–137.
9. Wu Z, Martin KO, Javitt NB, Chiang JYL (1999) Structure and functions of
human oxysterol 7a-hydroxylase cDNAs and gene CYP7B1. J Lipid Res 40:
2195–2203.
10. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, et al. (2000) Molecular
Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors. Mol
Cell 6: 507–515.
11. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, et al. (1999)
Identification of a Nuclear Receptor for Bile Acids. Science 284: 1362–1365.
12. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, et al. (1999)
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor. Science 284:
1365–1368.
Ovarian Bile Acid Synthesis
PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e733313. Chiang JYL, Kimmel R, Weinberger C, Stroup D (2000) Farnesoid X Receptor
Responds to Bile Acids and Represses Cholesterol 7a-Hydroxylase Gene
(CYP7A1) Transcription. J Biol Chem 275: 10918–10924.
14. Fiorucci S, Clerici C, Antonelli E, Orlandi S, Goodwin B, et al. (2005) Protective
Effects of 6-Ethyl Chenodeoxycholic Acid, a Farnesoid X Receptor Ligand, in
Estrogen-Induced Cholestasis. J Pharm Exp Ther 313: 604–612.
15. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, et al. (2000) A
Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1
Repress Bile Acid Biosynthesis. Mol Cell 6: 517–526.
16. Saxena D, Escamilla-Hernandez R, Little-Ihrig L, Zeleznik AJ (2007) Liver
Receptor Homolog-1 and Steroidogenic Factor-1 Have Similar Actions on Rat
Granulosa Cell Steroidogenesis. Endocrinol 148: 726–734.
17. Duggavathi R, Volle DH, Mataki C, Antal MC, Messaddeq N, et al. (2008)
Liver receptor homolog 1 is essential for ovulation. Genes & Dev 22: 1871–1876.
18. Mendelson CR, Kamat A (2007) Mechanisms in the regulation of aromatase in
developing ovary and placenta. J Ster Biochem Mol Biol 106: 62–70.
19. Suchanek E, Simunic V, Kopjar B, Macas E, Griselj V, et al. (1988) Lipid and
lipoprotein contents of human follicular fluid. J Clin Chem Clin Biochem 26:
543–547.
20. McNatty KP, Makris A, DeGrazia C, Osathanondh R, Ryan KJ (1979) The
production of progesterone, androgens, and estrogens by granulosa cells, thecal
tissue, and stromal tissue from human ovaries in vitro. J Clin Endocrinol Metab
49: 687–699.
21. Franchimont P, Hazee-Hagelstein MT, Hazout A, Frydman R, Schatz B, et al.
(1989) Correlation between follicular fluid content and the results of in vitro
fertilization and embryo transfer. Fertil Steril 52: 1006–1011.
22. Ng TB, Tam PP, Loong EP (1993) Levels of insulin and cholesterol in human
follicular fluid. Int J Fertil Menopaus Stud 38: 316–319.
23. Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, et al. (2002) Differential
Regulation of Rat and Human CYP7A1 by the Nuclear Oxysterol Receptor
Liver X Receptor-a. Mol Endocrinol 17: 386–394.
24. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ (1996) An oxysterol
signaling pathway mediated by the nuclear receptor LXRa. Nature 383:
728–731.
25. Lehmann JM, Kleiwer SA, Moore LB, Smith-Oliver TA, Oliver BB, et al. (1997)
Activation of the Nuclear Receptor LXR by Oxysterols Defines a New
Hormone Response Pathway. J Biol Chem 272: 3137–3140.
26. Hall E, Hylemon P, Vlahcevic Z, Mallonee D, Valerie K, et al. (2001)
Overexpression of CYP27 in hepatic and extrahepatic cells: role in the
regulation of cholesterol homeostasis. Am J Physiol Gastrointest Liver Physiol
281: G293–301.
27. Ishida H, Kuruta Y, Gotoh O, Yamashita C, Yoshida Y, et al. (1999) Structure,
Evolution, and Liver-Specific Expression of Sterol 12a-Hydroxylase P450
(CYP8B). J Biochem 126: 19–25.
28. Hinshelwood MM, Shelton JM, Richardson JA, Mendelsen CR (2005)
Temporal and Spatial Expression of Liver Receptor Homolog-1 (LRH-1)
During Embryogenesis Suggests a Potential Role in Gonadal Development. Dev
Dynam 234: 159–168.
29. Zimon A, Erat A, Von Wald T, Bissell B, Koulova A, et al. (2006) Genes invoked
in the ovarian transition to menopause. Nucl Acid Res 34: 3279–3287.
Ovarian Bile Acid Synthesis
PLoS ONE | www.plosone.org 6 October 2009 | Volume 4 | Issue 10 | e7333